<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37129502</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2083</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>15</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>20</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>Activation of the cGAS-STING innate immune response in cells with deficient mitochondrial topoisomerase TOP1MT.</ArticleTitle><Pagination><StartPage>2422</StartPage><EndPage>2440</EndPage><MedlinePgn>2422-2440</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/hmg/ddad062</ELocationID><Abstract><AbstractText>The recognition that cytosolic mitochondrial DNA (mtDNA) activates cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) innate immune signaling has unlocked novel disease mechanisms. Here, an uncharacterized variant predicted to affect TOP1MT function, P193L, was discovered in a family with multiple early onset autoimmune diseases, including Systemic Lupus Erythematosus (SLE). Although there was no previous genetic association between TOP1MT and autoimmune disease, the role of TOP1MT as a regulator of mtDNA led us to investigate whether TOP1MT could mediate the release of mtDNA to the cytosol, where it could then activate the cGAS-STING innate immune pathway known to be activated in SLE and other autoimmune diseases. Through analysis of cells with reduced TOP1MT expression, we show that loss of TOP1MT results in release of mtDNA to the cytosol, which activates the cGAS-STING pathway. We also characterized the P193L variant for its ability to rescue several TOP1MT functions when expressed in TOP1MT knockout cells. We show that the P193L variant is not fully functional, as its re-expression at high levels was unable to rescue mitochondrial respiration deficits, and only showed partial rescue for other functions, including repletion of mtDNA replication following depletion, nucleoid size, steady state mtDNA transcripts levels and mitochondrial morphology. Additionally, expression of P193L at endogenous levels was unable to rescue mtDNA release-mediated cGAS-STING signaling. Overall, we report a link between TOP1MT and mtDNA release leading to cGAS-STING activation. Moreover, we show that the P193L variant has partial loss of function that may contribute to autoimmune disease susceptibility via cGAS-STING mediated activation of the innate immune system.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al Khatib</LastName><ForeName>Iman</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Molecular Biology, Cumming School of Medicine, Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta T2N 4N1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Jingti</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Molecular Biology, Cumming School of Medicine, Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta T2N 4N1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Yuanjiu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbial Pathogenesis and Immunology, School of Medicine, Texas A&amp;M University, Bryan, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Odio</LastName><ForeName>Sylvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbial Pathogenesis and Immunology, School of Medicine, Texas A&amp;M University, Bryan, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas</LastName><ForeName>Gladys R</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>The Salk Institute for Biological Studies, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newman</LastName><ForeName>Laura E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>The Salk Institute for Biological Studies, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Brian K</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Norwegian PSC Research Center, Oslo University Hospital, Rikshospitalet, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Symes</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Geomatics Engineering, Schulich School of Engineering, University of Calgary, Calgary, Alberta T2N 1N4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hongliang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Shar-Yin N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pommier</LastName><ForeName>Yves</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Aneal</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Discovery DNA, Calgary, Alberta T2L 1Y8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>M.A.G.I.C. Clinic Ltd. (Metabolics and Genetics in Calgary).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Cumming School of Medicine, University of Calgary, Alberta Children's Hospital Research Institute, Calgary, Alberta T2M OL6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shadel</LastName><ForeName>Gerald S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>The Salk Institute for Biological Studies, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>West</LastName><ForeName>Andrew Phillip</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Microbial Pathogenesis and Immunology, School of Medicine, Texas A&amp;M University, Bryan, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibson</LastName><ForeName>William T</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Faculty of Medicine, British Columbia Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shutt</LastName><ForeName>Timothy E</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>Departments of Medical Genetics and Biochemistry &amp; Molecular Biology, Cumming School of Medicine, Alberta Children's Hospital Research Institute, Hotchkiss Brain Institute, Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta T2N 4N1, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>RC</Acronym><Agency>CCR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K99 GM141482</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 HL160141</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>Z01 BC006161</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL148153</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR069876</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004272">DNA, Mitochondrial</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="D009713">Nucleotidyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.99.1.2</RegistryNumber><NameOfSubstance UI="C000629910">TOP1MT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.99.1.2</RegistryNumber><NameOfSubstance UI="C000630064">Top1mt protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="C578390">cGAS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="C578391">cGAS protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C532857">STING1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C530855">Sting1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004272" MajorTopicYN="N">DNA, Mitochondrial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009713" MajorTopicYN="N">Nucleotidyltransferases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>10</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37129502</ArticleId><ArticleId IdType="pmc">PMC10360396</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddad062</ArticleId><ArticleId IdType="pii">7147887</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wincup, C. and Radziszewska, A. (2021) Abnormal mitochondrial physiology in the pathogenesis of systemic lupus erythematosus. Rheum. Dis. Clin. N. Am., 47, 427&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pubmed">34215372</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, S.K., Zhang, H.R., Shi, S.P., Zhu, Y.Q., Song, N., Dai, Q., Zhang, W., Gui, M. and Zhang, H. (2020) The role of mitochondria in systemic lupus erythematosus: a glimpse of various Pathogenetic mechanisms. Curr. Med. Chem., 27, 3346&#x2013;3361.</Citation><ArticleIdList><ArticleId IdType="pubmed">30479205</ArticleId></ArticleIdList></Reference><Reference><Citation>Alperin, J.M., Ortiz-Fern&#xe1;ndez, L. and Sawalha, A.H. (2018) Monogenic lupus: a developing paradigm of disease. Front. Immunol., 9, 2496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6232876</ArticleId><ArticleId IdType="pubmed">30459768</ArticleId></ArticleIdList></Reference><Reference><Citation>Bursztejn, A.C., Briggs, T.A., del &#xa0;Toro Duany, Y., Anderson, B.H., O'Sullivan, J., Williams, S.G., Bodemer, C., Fraitag, S., Gebhard, F., Leheup, B. &#xa0;et al. (2015) Unusual cutaneous features associated with a heterozygous gain-of-function mutation in IFIH1: overlap between Aicardi-Gouti&#xe8;res and singleton-Merten syndromes. Br. J. Dermatol., 173, 1505&#x2013;1513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4745891</ArticleId><ArticleId IdType="pubmed">26284909</ArticleId></ArticleIdList></Reference><Reference><Citation>An, J., Briggs, T.A., Dumax-Vorzet, A., Alarc&#xf3;n-Riquelme, M.E., Belot, A., Beresford, M., Bruce, I.N., Carvalho, C., Chaperot, L., Frosteg&#xe5;rd, J. &#xa0;et al. (2017) Tartrate-resistant acid phosphatase deficiency in the predisposition to systemic lupus erythematosus. Arthritis Rheumatol, 69, 131&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">27390188</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow, Y.J., Chase, D.S., Lowenstein Schmidt, J., Szynkiewicz, M., Forte, G.M., Gornall, H.L., Oojageer, A., Anderson, B., Pizzino, A., Helman, G. &#xa0;et al. (2015) Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am. J. Med. Genet. A, 167a, 296&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4382202</ArticleId><ArticleId IdType="pubmed">25604658</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyall, S.D., Brown, M.T. and Johnson, P.J. (2004) Ancient Invasions: From Endosymbionts to Organelles. Science &#xa0;(New York, N.Y.) &#xa0;304, pp. 253&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">15073369</ArticleId></ArticleIdList></Reference><Reference><Citation>Kukat, C., Wurm, C.A., Spahr, H., Falkenberg, M., Larsson, N.G. and Jakobs, S. (2011) Super-resolution microscopy reveals that mammalian mitochondrial nucleoids have a uniform size and frequently contain a single copy of mtDNA. Proc. Natl. Acad. Sci. USA, 108, 13534&#x2013;13539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3158146</ArticleId><ArticleId IdType="pubmed">21808029</ArticleId></ArticleIdList></Reference><Reference><Citation>Kausar, S., Yang, L., Abbas, M.N., Hu, X., Zhao, Y., Zhu, Y. and Cui, H. (2020) Mitochondrial DNA: a Key regulator of anti-microbial innate immunity. Genes (Basel), 11:86, 1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7017290</ArticleId><ArticleId IdType="pubmed">31940818</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng, Z., Abrams, S.T., Austin, J., Toh, J., Wang, S.S., Wang, Z., Yu, Q., Yu, W., Toh, C.H. and Wang, G. (2020) The central role and possible mechanisms of bacterial DNAs in sepsis development. Mediat. Inflamm., 2020, 7418342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7479481</ArticleId><ArticleId IdType="pubmed">32934605</ArticleId></ArticleIdList></Reference><Reference><Citation>Luna-S&#xe1;nchez, M., Bianchi, P. and Quintana, A. (2021) Mitochondria-induced immune response as a trigger for neurodegeneration: a pathogen from within. Int. J. Mol. Sci., 22:8523, 1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8395232</ArticleId><ArticleId IdType="pubmed">34445229</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley, J.S. and Tait, S.W. (2020) Mitochondrial DNA in inflammation and immunity. EMBO Rep., 21, e49799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7132203</ArticleId><ArticleId IdType="pubmed">32202065</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepelley, A., Wai, T. and Crow, Y.J. (2021) Mitochondrial nucleic acid as a driver of pathogenic type I interferon induction in Mendelian disease. Front. Immunol., 12, 729763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8428523</ArticleId><ArticleId IdType="pubmed">34512665</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki, T. and Galluzzi, L. (2022) BAX and BAK dynamics control mitochondrial DNA release during apoptosis. Cell Death Differ., 29, 1296&#x2013;1298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9177580</ArticleId><ArticleId IdType="pubmed">35347233</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrushev, M., Kasymov, V., Patrusheva, V., Ushakova, T., Gogvadze, V. and Gaziev, A. (2004) Mitochondrial permeability transition triggers the release of mtDNA fragments. Cell. Mol. Life Sci., 61, 3100&#x2013;3103.</Citation><ArticleIdList><ArticleId IdType="pubmed">15583871</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, J., Gupta, R., Blanco, L.P., Yang, S., Shteinfer-Kuzmine, A., Wang, K., Zhu, J., Yoon, H.E., Wang, X., Kerkhofs, M. &#xa0;et al. (2019) VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease. Science (New York, N.Y.), 366, 1531&#x2013;1536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8325171</ArticleId><ArticleId IdType="pubmed">31857488</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang, C., Wei, X. and Wei, Y. (2016) Mitochondrial DNA in the regulation of innate immune responses. Protein Cell, 7, 11&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4707157</ArticleId><ArticleId IdType="pubmed">26498951</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, Y., Gu, R., Gan, D., Hu, F., Li, G. and Xu, G. (2020) Mitochondrial DNA drives noncanonical inflammation activation via cGAS-STING signaling pathway in retinal microvascular endothelial cells. Cell Commun. Signal, 18, 172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7592595</ArticleId><ArticleId IdType="pubmed">33115500</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, L.S., Hong, Z., Wu, W., Xiong, S., Zhong, M., Gao, X., Rehman, J. and Malik, A.B. (2020) mtDNA activates cGAS Signaling and suppresses the YAP-mediated endothelial cell proliferation program to promote inflammatory injury. Immunity, 52, 475&#x2013;486.e475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7266657</ArticleId><ArticleId IdType="pubmed">32164878</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai, J., Cervantes, C., He, S., He, J., Plasko, G.R., Wen, J., Li, Z., Yin, D., Zhang, C., Liu, M. &#xa0;et al. (2020) Mitochondrial stress-activated cGAS-STING pathway inhibits thermogenic program and contributes to overnutrition-induced obesity in mice. Commun. Biol, 3, 257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7244732</ArticleId><ArticleId IdType="pubmed">32444826</ArticleId></ArticleIdList></Reference><Reference><Citation>Decout, A., Katz, J.D., Venkatraman, S. and Ablasser, A. (2021) The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat. Rev. Immunol., 21, 548&#x2013;569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8029610</ArticleId><ArticleId IdType="pubmed">33833439</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobbs, N., Burnaevskiy, N., Chen, D., Gonugunta, V.K., Alto, N.M. and Yan, N. (2015) STING activation by translocation from the ER is associated with infection and autoinflammatory disease. Cell Host Microbe., 18, 157&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4537353</ArticleId><ArticleId IdType="pubmed">26235147</ArticleId></ArticleIdList></Reference><Reference><Citation>West, A.P., Khoury-Hanold, W., Staron, M., Tal, M.C., Pineda, C.M., Lang, S.M., Bestwick, M., Duguay, B.A., Raimundo, N., MacDuff, D.A. &#xa0;et al. (2015) Mitochondrial DNA stress primes the antiviral innate immune response. Nature, 520, 553&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4409480</ArticleId><ArticleId IdType="pubmed">25642965</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Odio, S., Lei, Y., Gispert, S., Maletzko, A., Key, J., Menissy, S.S., Wittig, I., Auburger, G. and West, A.P. (2021) Loss of mitochondrial protease CLPP activates type I IFN responses through the mitochondrial DNA-cGAS-STING Signaling Axis. J. Immunol., 206, 1890&#x2013;1900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8026707</ArticleId><ArticleId IdType="pubmed">33731338</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui, H., Ito, J., Matsui, N., Uechi, T., Onodera, O. and Kakita, A. (2021) Cytosolic dsDNA of mitochondrial origin induces cytotoxicity and neurodegeneration in cellular and zebrafish models of Parkinson's disease. Nat. Commun., 12, 3101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8149644</ArticleId><ArticleId IdType="pubmed">34035300</ArticleId></ArticleIdList></Reference><Reference><Citation>Sliter, D.A., Martinez, J., Hao, L., Chen, X., Sun, N., Fischer, T.D., Burman, J.L., Li, Y., Zhang, Z., Narendra, D.P. &#xa0;et al. (2018) Parkin and PINK1 mitigate STING-induced inflammation. Nature, 561, 258&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362342</ArticleId><ArticleId IdType="pubmed">30135585</ArticleId></ArticleIdList></Reference><Reference><Citation>Du, S., Chen, G., Yuan, B., Hu, Y., Yang, P., Chen, Y., Zhao, Q., Zhou, J., Fan, J. and Zeng, Z. (2021) DNA sensing and associated type 1 interferon signaling contributes to progression of radiation-induced liver injury. Cell Mol. Immunol., 18, 1718&#x2013;1728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8245603</ArticleId><ArticleId IdType="pubmed">32203191</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo, X., Li, H., Ma, L., Zhou, J., Guo, X., Woo, S.L., Pei, Y., Knight, L.R., Deveau, M., Chen, Y. &#xa0;et al. (2018) Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice. Gastroenterology, 155, 1971&#x2013;1984.e1974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6279491</ArticleId><ArticleId IdType="pubmed">30213555</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen, M.K., Skouboe, M.K., Boularan, C., Vernejoul, F., Lioux, T., Leknes, S.L., Berthelsen, M.F., Riedel, M., Cai, H., Joseph, J.V. &#xa0;et al. (2020) The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma. Oncogene, 39, 1652&#x2013;1664.</Citation><ArticleIdList><ArticleId IdType="pubmed">31740782</ArticleId></ArticleIdList></Reference><Reference><Citation>Maekawa, H., Inoue, T., Ouchi, H., Jao, T.M., Inoue, R., Nishi, H., Fujii, R., Ishidate, F., Tanaka, T., Tanaka, Y. &#xa0;et al. (2019) Mitochondrial damage causes inflammation via cGAS-STING Signaling in acute kidney injury. Cell Rep., 29, 1261&#x2013;1273.e1266.</Citation><ArticleIdList><ArticleId IdType="pubmed">31665638</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung, K.W., Dhillon, P., Huang, S., Sheng, X., Shrestha, R., Qiu, C., Kaufman, B.A., Park, J., Pei, L., Baur, J. &#xa0;et al. (2019) Mitochondrial damage and activation of the STING pathway lead to renal inflammation and fibrosis. Cell Metab., 30, 784&#x2013;799.e785.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7054893</ArticleId><ArticleId IdType="pubmed">31474566</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, Q., Wei, Y., Pandol, S.J., Li, L. and Habtezion, A. (2018) STING Signaling promotes inflammation in experimental acute pancreatitis. Gastroenterology, 154, 1822&#x2013;1835 &#xa0;e1822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6112120</ArticleId><ArticleId IdType="pubmed">29425920</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobek, S. and Boege, F. (2014) DNA topoisomerases in mtDNA maintenance and ageing. Exp. Gerontol., 56, 135&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">24440386</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, H., Barcelo, J.M., Lee, B., Kohlhagen, G., Zimonjic, D.B., Popescu, N.C. and Pommier, Y. (2001) Human mitochondrial topoisomerase I. Proc. Natl. Acad. Sci. USA, 98, 10608&#x2013;10613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC58513</ArticleId><ArticleId IdType="pubmed">11526219</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, X., Li, X.H., Ma, X., Wang, Z.H., Lu, S. and Guo, Y.L. (2006) Redox-induced apoptosis of human oocytes in resting follicles in vitro. J. Soc. Gynecol. Investig., 13, 451&#x2013;458.</Citation><ArticleIdList><ArticleId IdType="pubmed">16879991</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, H. and Pommier, Y. (2008) Mitochondrial topoisomerase I sites in the regulatory D-loop region of mitochondrial DNA. Biochemistry, 47, 11196&#x2013;11203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2597090</ArticleId><ArticleId IdType="pubmed">18826252</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, H., Zhang, Y.W., Yasukawa, T., Dalla Rosa, I., Khiati, S. and Pommier, Y. (2014) Increased negative supercoiling of mtDNA in TOP1mt knockout mice and presence of topoisomerases II&#x3b1; and II&#x3b2; in vertebrate mitochondria. Nucleic Acids Res., 42, 7259&#x2013;7267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4066791</ArticleId><ArticleId IdType="pubmed">24803675</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobek, S., Dalla Rosa, I., Pommier, Y., Bornholz, B., Kalfalah, F., Zhang, H., Wiesner, R.J., von &#xa0;Kleist-Retzow, J.C., Hillebrand, F., Schaal, H. &#xa0;et al. (2013) Negative regulation of mitochondrial transcription by mitochondrial topoisomerase I. Nucleic Acids Res., 41, 9848&#x2013;9857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3834834</ArticleId><ArticleId IdType="pubmed">23982517</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Khatib, I., Deng, J., Symes, A., Kerr, M., Zhang, H., Huang, S.N., Pommier, Y., Khan, A. and Shutt, T.E. (2022) Functional characterization of two variants of mitochondrial topoisomerase TOP1MT that impact regulation of the mitochondrial genome. J. Biol. Chem., 298, 102420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9513266</ArticleId><ArticleId IdType="pubmed">36030054</ArticleId></ArticleIdList></Reference><Reference><Citation>Han, S., Zhuang, H., Shumyak, S., Yang, L. and Reeves, W.H. (2015) Mechanisms of autoantibody production in systemic lupus erythematosus. Front. Immunol., 6, 228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4429614</ArticleId><ArticleId IdType="pubmed">26029213</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaniv, G., Twig, G., Shor, D.B., Furer, A., Sherer, Y., Mozes, O., Komisar, O., Slonimsky, E., Klang, E., Lotan, E. &#xa0;et al. (2015) A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmun. Rev., 14, 75&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">25449682</ArticleId></ArticleIdList></Reference><Reference><Citation>Rekvig, O.P. (2015) Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks. Clin. Exp. Immunol., 179, 5&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4260890</ArticleId><ArticleId IdType="pubmed">24533624</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai, Y., Tong, Y., Liu, Y. and Hu, H. (2018) Self-dsDNA in the pathogenesis of systemic lupus erythematosus. Clin. Exp. Immunol., 191, 1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5721232</ArticleId><ArticleId IdType="pubmed">28836661</ArticleId></ArticleIdList></Reference><Reference><Citation>Fredi, M., Cavazzana, I., Zanola, A., Carabellese, N., Tincani, A., Mahler, M. and Franceschini, F. (2017) Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies. Lupus, 26, 1121&#x2013;1122.</Citation><ArticleIdList><ArticleId IdType="pubmed">28420064</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojanov, L., Satoh, M., Dooley, M.A., Kuwana, M., Jennette, J.C. and Reeves, W.H. (1995) Autoantibodies to topoisomerase I in a patient with systemic lupus erythematosus without features of scleroderma. Lupus, 4, 314&#x2013;317.</Citation><ArticleIdList><ArticleId IdType="pubmed">8528230</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamidou, M.A., Audrain, M.A., Masseau, A., Agard, C. and Moreau, A. (2006) Anti-topoisomerase I antibodies in systemic lupus erythematosus as a marker of severe nephritis. Clin. Rheumatol., 25, 542&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pubmed">16525896</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahler, M., Silverman, E.D., Schulte-Pelkum, J. and Fritzler, M.J. (2010) Anti-Scl-70 (topo-I) antibodies in SLE: myth or reality? &#xa0;Autoimmun. Rev., 9, 756&#x2013;760.</Citation><ArticleIdList><ArticleId IdType="pubmed">20601198</ArticleId></ArticleIdList></Reference><Reference><Citation>Budde, P., Zucht, H.D., Vordenb&#xe4;umen, S., Goehler, H., Fischer-Betz, R., Gamer, M., Marquart, K., Rengers, P., Richter, J., Lueking, A. &#xa0;et al. (2016) Multiparametric detection of autoantibodies in systemic lupus erythematosus. Lupus, 25, 812&#x2013;822.</Citation><ArticleIdList><ArticleId IdType="pubmed">27252257</ArticleId></ArticleIdList></Reference><Reference><Citation>Thim-Uam, A., Prabakaran, T., Tansakul, M., Makjaroen, J., Wongkongkathep, P., Chantaravisoot, N., Saethang, T., Leelahavanichkul, A., Benjachat, T., Paludan, S. &#xa0;et al. (2020) STING mediates lupus via the activation of conventional dendritic cell maturation and Plasmacytoid dendritic. Cell Differentiation, iScience, 23, 101530.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7502826</ArticleId><ArticleId IdType="pubmed">33083760</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y., Wilson, H.L. and Kiss-Toth, E. (2017) Regulating STING in health and disease. J Inflamm (Lond), 14, 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5463399</ArticleId><ArticleId IdType="pubmed">28596706</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeremiah, N., Neven, B., Gentili, M., Callebaut, I., Maschalidi, S., Stolzenberg, M.C., Goudin, N., Fr&#xe9;mond, M.L., Nitschke, P., Molina, T.J. &#xa0;et al. (2014) Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J. Clin. Invest., 124, 5516&#x2013;5520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4348945</ArticleId><ArticleId IdType="pubmed">25401470</ArticleId></ArticleIdList></Reference><Reference><Citation>Arneth, B. (2019) Systemic lupus erythematosus and DNA degradation and elimination defects. Front. Immunol., 10, 1697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6692764</ArticleId><ArticleId IdType="pubmed">31440232</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson, W.T., Farooqi, I.S., Moreau, M., DePaoli, A.M., Lawrence, E., O'Rahilly, S. and Trussell, R.A. (2004) Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy. J. Clin. Endocrinol. Metab., 89, 4821&#x2013;4826.</Citation><ArticleIdList><ArticleId IdType="pubmed">15472169</ArticleId></ArticleIdList></Reference><Reference><Citation>Khiati, S., Baechler, S.A., Factor, V.M., Zhang, H., Huang, S.Y., Dalla Rosa, I., Sourbier, C., Neckers, L., Thorgeirsson, S.S. and Pommier, Y. (2015) Lack of mitochondrial topoisomerase I (TOP1mt) impairs liver regeneration. Proc. Natl. Acad. Sci. USA, 112, 11282&#x2013;11287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4568654</ArticleId><ArticleId IdType="pubmed">26305952</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent, J., Adura, C., Gao, P., Luz, A., Lama, L., Asano, Y., Okamoto, R., Imaeda, T., Aida, J., Rothamel, K. &#xa0;et al. (2017) Small molecule inhibition of cGAS reduces interferon expression in primary macrophages from autoimmune mice. Nat. Commun., 8, 750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5622107</ArticleId><ArticleId IdType="pubmed">28963528</ArticleId></ArticleIdList></Reference><Reference><Citation>Suter, M.A., Tan, N.Y., Thiam, C.H., Khatoo, M., MacAry, P.A., Angeli, V., Gasser, S. and Zhang, Y.L. (2021) cGAS-STING cytosolic DNA sensing pathway is suppressed by JAK2-STAT3 in tumor cells. Sci. Rep., 11, 7243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8012641</ArticleId><ArticleId IdType="pubmed">33790360</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;pin, G. and Gantier, M.P. (2018) Assessing the cGAS-cGAMP-STING activity of cancer cells. Methods Mol. Biol. (Clifton, N.J.), 1725, 257&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">29322423</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, H., Zhang, Y.W., Yasukawa, T., Dalla Rosa, I., Khiati, S. and Pommier, Y. (2014) Increased negative supercoiling of mtDNA in TOP1mt knockout mice and presence of topoisomerases IIalpha and IIbeta in vertebrate mitochondria. Nucleic Acids Res., 42, 7259&#x2013;7267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4066791</ArticleId><ArticleId IdType="pubmed">24803675</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaginuma, K., Kobayashi, M., Taira, M. and Koike, K. (1982) A new RNA polymerase and in vitro transcription of the origin of replication from rat mitochondrial DNA. Nucleic Acids Res., 10, 7531&#x2013;7542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC327028</ArticleId><ArticleId IdType="pubmed">6760128</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzan, J.M. and Low, R.L. (1988) Preference of human mitochondrial RNA polymerase for superhelical templates with mitochondrial promoters. Biochem. Biophys. Res. Commun., 152, 22&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">3358762</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuoh, A., Ohgaki, K., Hatae, H., Kuraoka, I., Aoki, Y., Uchiumi, T., Jacobs, H.T. and Kang, D. (2009) DNA conformation-dependent activities of human mitochondrial RNA polymerase. Genes Cells, 14, 1029&#x2013;1042.</Citation><ArticleIdList><ArticleId IdType="pubmed">19624753</ArticleId></ArticleIdList></Reference><Reference><Citation>Barat-Gueride, M., Dufresne, C. and Rickwood, D. (1989) Effect of DNA conformation on the transcription of mitochondrial DNA. Eur. J. Biochem., 183, 297&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">2759085</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollo, O. and Sondheimer, N. (2017) Topological requirements of the mitochondrial heavy-strand promoters. Transcription, 8, 307&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5703240</ArticleId><ArticleId IdType="pubmed">28841355</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang, J.X., Thompson, K., Taylor, R.W. and Ol&#xe1;hov&#xe1;, M. (2020) Mitochondrial OXPHOS biogenesis: co-regulation of protein synthesis, import, and assembly pathways. Int. J. Mol. Sci., 21:3820, 1&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7312649</ArticleId><ArticleId IdType="pubmed">32481479</ArticleId></ArticleIdList></Reference><Reference><Citation>Baechler, S.A., Factor, V.M., Dalla Rosa, I., Ravji, A., Becker, D., Khiati, S., Miller Jenkins, L.M., Lang, M., Sourbier, C., Michaels, S.A. &#xa0;et al. (2019) The mitochondrial type IB topoisomerase drives mitochondrial translation and carcinogenesis. Nat. Commun., 10, 83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6325124</ArticleId><ArticleId IdType="pubmed">30622257</ArticleId></ArticleIdList></Reference><Reference><Citation>Taguchi, T., Mukai, K., Takaya, E. and Shindo, R. (2021) STING operation at the ER/Golgi Interface. Front. Immunol., 12, 646304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8126659</ArticleId><ArticleId IdType="pubmed">34012437</ArticleId></ArticleIdList></Reference><Reference><Citation>Khiati, S., Dalla Rosa, I., Sourbier, C., Ma, X., Rao, V.A., Neckers, L.M., Zhang, H. and Pommier, Y. (2014) Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of doxorubicin cardiotoxicity. Clin. Cancer Res., 20, 4873&#x2013;4881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4167185</ArticleId><ArticleId IdType="pubmed">24714774</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, H., Seol, Y., Agama, K., Neuman, K.C. and Pommier, Y. (2017) Distribution bias and biochemical characterization of TOP1MT single nucleotide variants. Sci. Rep., 7, 8614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5561071</ArticleId><ArticleId IdType="pubmed">28819183</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, W., Shen, P., Thiyagarajan, S., Lin, S., Palm, C., Horvath, R., Klopstock, T., Cutler, D., Pique, L., Schrijver, I. &#xa0;et al. (2011) Identification of rare DNA variants in mitochondrial disorders with improved array-based sequencing. Nucleic Acids Res., 39, 44&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3017602</ArticleId><ArticleId IdType="pubmed">20843780</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei, Y., Guerra Martinez, C., Torres-Odio, S., Bell, S.L., Birdwell, C.E., Bryant, J.D., Tong, C.W., Watson, R.O., West, L.C. and West, A.P. (2021) Elevated type I interferon responses potentiate metabolic dysfunction, inflammation, and accelerated aging in mtDNA mutator mice. Sci. Adv., 7:eabe7548, 1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8153723</ArticleId><ArticleId IdType="pubmed">34039599</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepelley, A., Della Mina, E., Van Nieuwenhove, E., Waumans, L., Fraitag, S., Rice, G.I., Dhir, A., Fr&#xe9;mond, M.L., Rodero, M.P., Seabra, L. &#xa0;et al. (2021) Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3A. J. Exp. Med., 218:e20201560, 1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8374862</ArticleId><ArticleId IdType="pubmed">34387651</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamen, D.L. (2014) Environmental influences on systemic lupus erythematosus expression. Rheum. Dis. Clin. N. Am., 40, 401&#x2013;412, vii.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4198387</ArticleId><ArticleId IdType="pubmed">25034153</ArticleId></ArticleIdList></Reference><Reference><Citation>Perl, A. (2010) Pathogenic mechanisms in systemic lupus erythematosus. Autoimmunity, 43, 1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4046632</ArticleId><ArticleId IdType="pubmed">20014960</ArticleId></ArticleIdList></Reference><Reference><Citation>Lood, C., Blanco, L.P., Purmalek, M.M., Carmona-Rivera, C., De Ravin, S.S., Smith, C.K., Malech, H.L., Ledbetter, J.A., Elkon, K.B. and Kaplan, M.J. (2016) Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat. Med., 22, 146&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4742415</ArticleId><ArticleId IdType="pubmed">26779811</ArticleId></ArticleIdList></Reference><Reference><Citation>Leishangthem, B.D., Sharma, A. and Bhatnagar, A. (2016) Role of altered mitochondria functions in the pathogenesis of systemic lupus erythematosus. Lupus, 25, 272&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="pubmed">26385216</ArticleId></ArticleIdList></Reference><Reference><Citation>An, J., Durcan, L., Karr, R.M., Briggs, T.A., Rice, G.I., Teal, T.H., Woodward, J.J. and Elkon, K.B. (2017) Expression of cyclic GMP-AMP synthase in patients with systemic lupus erythematosus. Arthritis Rheumatol, 69, 800&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="pubmed">27863149</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato, Y., Park, J., Takamatsu, H., Konaka, H., Aoki, W., Aburaya, S., Ueda, M., Nishide, M., Koyama, S., Hayama, Y. &#xa0;et al. (2018) Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus. Ann. Rheum. Dis., 77, 1507&#x2013;1515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6161667</ArticleId><ArticleId IdType="pubmed">29945921</ArticleId></ArticleIdList></Reference><Reference><Citation>Meas, R., Burak, M.J. and Sweasy, J.B. (2017) DNA repair and systemic lupus erythematosus. DNA Repair (Amst), 56, 174&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5543809</ArticleId><ArticleId IdType="pubmed">28623091</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallai, K., Nagy, E., Derfalvy, B., M&#xfc;zes, G. and Gergely, P. (2005) Antinucleosome antibodies and decreased deoxyribonuclease activity in sera of patients with systemic lupus erythematosus. Clin. Diagn. Lab. Immunol., 12, 56&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC540196</ArticleId><ArticleId IdType="pubmed">15642985</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M. and Kuroda, Y. (2001) Mutation of DNASE1 in people with systemic lupus erythematosus. Nat. Genet., 28, 313&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">11479590</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mayouf, S.M., Sunker, A., Abdwani, R., Abrawi, S.A., Almurshedi, F., Alhashmi, N., Al Sonbul, A., Sewairi, W., Qari, A., Abdallah, E. &#xa0;et al. (2011) Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat. Genet., 43, 1186&#x2013;1188.</Citation><ArticleIdList><ArticleId IdType="pubmed">22019780</ArticleId></ArticleIdList></Reference><Reference><Citation>Zervou, M.I., Andreou, A., Matalliotakis, M., Spandidos, D.A., Goulielmos, G.N. and Eliopoulos, E.E. (2020) Association of the DNASE1L3 rs35677470 polymorphism with systemic lupus erythematosus, rheumatoid arthritis and systemic sclerosis: structural biological insights. Mol. Med. Rep., 22, 4492&#x2013;4498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7646740</ArticleId><ArticleId IdType="pubmed">33173951</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee-Kirsch, M.A., Gong, M., Chowdhury, D., Senenko, L., Engel, K., Lee, Y.A., de &#xa0;Silva, U., Bailey, S.L., Witte, T., Vyse, T.J. &#xa0;et al. (2007) Mutations in the gene encoding the 3&#x2032;-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat. Genet., 39, 1065&#x2013;1067.</Citation><ArticleIdList><ArticleId IdType="pubmed">17660818</ArticleId></ArticleIdList></Reference><Reference><Citation>Fye, J.M., Orebaugh, C.D., Coffin, S.R., Hollis, T. and Perrino, F.W. (2011) Dominant mutation of the TREX1 exonuclease gene in lupus and Aicardi-Goutieres syndrome. J. Biol. Chem., 286, 32373&#x2013;32382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3173215</ArticleId><ArticleId IdType="pubmed">21808053</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-L&#xf3;pez, L., Nieves-Plaza, M., Castro Mdel, R., Font, Y.M., Torres-Ramos, C.A., Vil&#xe1;, L.M. and Ayala-Pe&#xf1;a, S. (2014) Mitochondrial DNA damage is associated with damage accrual and disease duration in patients with systemic lupus erythematosus. Lupus, 23, 1133&#x2013;1141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4156531</ArticleId><ArticleId IdType="pubmed">24899636</ArticleId></ArticleIdList></Reference><Reference><Citation>Goffart, S., Hangas, A. and Pohjoismaki, J.L.O. (2019) Twist and turn-topoisomerase functions in mitochondrial DNA maintenance. Int. J. Mol. Sci., 20:2041, 1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6514783</ArticleId><ArticleId IdType="pubmed">31027213</ArticleId></ArticleIdList></Reference><Reference><Citation>Douarre, C., Sourbier, C., Dalla Rosa, I., Brata Das, B., Redon, C.E., Zhang, H., Neckers, L. and Pommier, Y. (2012) Mitochondrial topoisomerase I is critical for mitochondrial integrity and cellular energy metabolism. PLoS One, 7, e41094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3401127</ArticleId><ArticleId IdType="pubmed">22911747</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccinini, G., Cardellini, E., Reimer, G., Arnett, F.C. and Durban, E. (1991) An antigenic region of topoisomerase I in DNA polymerase chain reaction-generated fragments recognized by autoantibodies of scleroderma patients. Mol. Immunol., 28, 333&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">1712070</ArticleId></ArticleIdList></Reference><Reference><Citation>Hongliang Zhang, M.K. and Pommier, Y. &#xa0;Using mitochondrial TOP1 (TOP1mt) to probe the involvement of mitochondria in systemic lupus erythematosus. Virtual Keystone Symposia .</Citation></Reference><Reference><Citation>Dalla Rosa, I., Huang, S.Y., Agama, K., Khiati, S., Zhang, H. and Pommier, Y. (2014) Mapping topoisomerase sites in mitochondrial DNA with a poisonous mitochondrial topoisomerase I (Top1mt). J. Biol. Chem., 289, 18595&#x2013;18602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4140277</ArticleId><ArticleId IdType="pubmed">24798329</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, Z., Oeck, S., West, A.P., Mangalhara, K.C., Sainz, A.G., Newman, L.E., Zhang, X.O., Wu, L., Yan, Q., Bosenberg, M. &#xa0;et al. (2019) Mitochondrial DNA stress signalling protects the nuclear genome. Nat Metab, 1, 1209&#x2013;1218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7213273</ArticleId><ArticleId IdType="pubmed">32395698</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, M., Chen, P., Wang, L., Li, W., Chen, B., Liu, Y., Wang, H., Zhao, S., Ye, L., He, Y. &#xa0;et al. (2020) cGAS-STING, an important pathway in cancer immunotherapy. J. Hematol. Oncol., 13, 81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7310007</ArticleId><ArticleId IdType="pubmed">32571374</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabouny, R., Wong, R., Lee-Glover, L., Greenway, S.C., Sinasac, D.S., Khan, A. and Shutt, T.E. (2019) Characterization of the C584R variant in the mtDNA depletion syndrome gene FBXL4, reveals a novel role for FBXL4 as a regulator of mitochondrial fusion. Biochim. Biophys. Acta Mol. basis Dis., 1865, 165536.</Citation><ArticleIdList><ArticleId IdType="pubmed">31442532</ArticleId></ArticleIdList></Reference><Reference><Citation>

Newman, L.E., Tadepalle, N., Novak, S.W., Schiavon, C.R., Rojas, G.R., Chevez, J.A., Lemersal, I., Medina, M., Rocha, S., Towers, C.G. &#xa0;et al.  (2022) Endosomal removal and disposal of dysfunctional, immunostimulatory mitochondrial DNA. bioRxiv, 2022.2010.2012.511955. print:https://www.biorxiv.org/content/10.1101/2022.10.12.511955v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.10.12.511955v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatre, L.R.M. (2015) Mitochondrial medicine. In Edeas, V.W.M. (ed), Probing Mitochondrial Function. Vol. I, Springer, New York, pp. 133&#x2013;147.</Citation></Reference><Reference><Citation>Donkervoort, S., Sabouny, R., Yun, P., Gauquelin, L., Chao, K.R., Hu, Y., Al Khatib, I., T&#xf6;pf, A., Mohassel, P., Cummings, B.B. &#xa0;et al. (2019) MSTO1 mutations cause mtDNA depletion, manifesting as muscular dystrophy with cerebellar involvement. Acta Neuropathol., 138, 1013&#x2013;1031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6851037</ArticleId><ArticleId IdType="pubmed">31463572</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaton, J.S., Lin, Z.P., Sartorelli, A.C., Bonawitz, N.D. and Shadel, G.S. (2007) Ataxia-telangiectasia mutated kinase regulates ribonucleotide reductase and mitochondrial homeostasis. J. Clin. Invest., 117, 2723&#x2013;2734.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1952633</ArticleId><ArticleId IdType="pubmed">17786248</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek, M., DiMaio, F., Anishchenko, I., Dauparas, J., Ovchinnikov, S., Lee, G.R., Wang, J., Cong, Q., Kinch, L.N., Schaeffer, R.D. &#xa0;et al. (2021) Accurate prediction of protein structures and interactions using a three-track neural network. Science (New York, N.Y.), 373, 871&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7612213</ArticleId><ArticleId IdType="pubmed">34282049</ArticleId></ArticleIdList></Reference><Reference><Citation>van &#xa0;Zundert, G.C.P., Rodrigues, J., Trellet, M., Schmitz, C., Kastritis, P.L., Karaca, E., Melquiond, A.S.J., van &#xa0;Dijk, M., de &#xa0;Vries, S.J. and Bonvin, A. (2016) The HADDOCK2.2 web server: user-friendly integrative Modeling of biomolecular complexes. J. Mol. Biol., 428, 720&#x2013;725.</Citation><ArticleIdList><ArticleId IdType="pubmed">26410586</ArticleId></ArticleIdList></Reference><Reference><Citation>Honorato, R.V., Koukos, P.I., Jim&#xe9;nez-Garc&#xed;a, B., Tsaregorodtsev, A., Verlato, M., Giachetti, A., Rosato, A. and Bonvin, A. (2021) Structural biology in the clouds: the WeNMR-EOSC ecosystem. Front. Mol. Biosci., 8, 729513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8356364</ArticleId><ArticleId IdType="pubmed">34395534</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker, N.A., Sept, D., Joseph, S., Holst, M.J. and McCammon, J.A. (2001) Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl. Acad. Sci. USA, 98, 10037&#x2013;10041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC56910</ArticleId><ArticleId IdType="pubmed">11517324</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>